1. Mottet N, Cornford P, van den Bergh RCN, Briers E, Eberli D et al EAU - EANM - ESTRO - ESUR - ISUP – SIOG Guidelines on Prostate Cancer. https://uroweb.org/guidelines/prostate-cancer.
2. Polish National Cancer Registry. https://onkologia.org.pl/pl.
3. Evaluating the combined effect of comorbidity and prostate-specific antigen kinetics on the risk of death in men after prostate-specific antigen recurrence;Wo;J Clin Oncol,2009
4. Plasma osteopontin as a biomarker of prostate cancer aggression: relationship to risk category and treatment response;Thoms;British Journal of Cancer,2012
5. Haubein NC Osteopontin is a marker for cancer aggressiveness and patient survival;Weber;British Journal of Cancer,2010